Drug Development

Breaking News | Collaborations & Alliances | Drug Development

BioMoti Partners with Pharma Company to Develop Ovarian Cancer Treatment

Dr. John Beadle joins Board of Directors as chairman.

05.19.22

Breaking News | Drug Development | Promotions & Moves

Thabor Therapeutics Appoints Jérémie Mariau as CEO

Mariau will lead Thabor towards the next stages in its development.

05.17.22

Breaking News | Drug Development

Catalent Introduces UpTempo Virtuoso Platform

Standardizes and streamlines many time-consuming steps in AAV manufacturing to significantly reduce gene therapy development time.

05.16.22

Breaking News | Clinical Trials | Drug Development

Elicio Therapeutics Enters Clinical Supply Agreement with Regeneron

Aims to evaluate the safety and efficacy of Elicio’s ELI-002 in combination with Regeneron’s Libtayo (cemiplimab) in patients with KRAS-driven tumors.

05.16.22

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Bora Pharmaceuticals Acquires CDMO Assets from Eden Biologics

Establishes leadership position in Taiwan's CDMO sector and plans to expand into the global CDMO market.

05.12.22

Breaking News | Drug Development

Avacta Relocates Therapeutics Division to Scale Space, Imperial College White City Campus

Brings its Therapeutics research and development teams together in a single space to accelerate its therapeutic programs into the clinic.

05.11.22

Breaking News | Drug Development | Industry News

CMC Pharmaceuticals Expands Chemical Defense Portfolio

Awarded Small Business Innovation Research grant by the Department of Defense.

05.10.22

Breaking News | Collaborations & Alliances | Drug Development | Preclinical Outsourcing

Hovione Signs Exclusive License Agreement with JIXING

JIXING will receive global rights to JX08 and lead the full life cycle of development from preclinical through commercialization.

05.09.22

Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development

ALSA Ventures, Lonza Partner to Provide Biotech Support & Services

Lonza will assist ALSA Ventures’ portfolio companies with services supporting de-risking, early development and manufacturing of next-generation modalities.

05.09.22

Breaking News | Drug Development

Byondis Partners with Medac to Commercialize Antibody-Drug Conjugate

SYD985 targets a range of HER2-expressing cancers such as metastatic breast and endometrial (uterine) tumors.

05.03.22

Breaking News | Drug Development

Endo Purchases Development-Stage, Ready-to-Use Injectable Product Candidates from Nevakar

Endo's Par Sterile Products business will commercialize the products in the United States.

05.03.22

Biologics, Proteins, Vaccines | Drug Development

JSR Life Sciences Names Mark W. Womack as CEO of KBI & Selexis

Womack will be responsible for the strategic vision, continued growth, and organizational culture of both organizations.

05.03.22

Virpax Selects Kindeva Drug Delivery as Development Partner

Will bring Diclofenac pMDI from an existing lab-scale formulation to a phase II and III clinical supply.

05.02.22

Breaking News | Drug Development

Nektar Therapeutics Initiates Strategic Reorganization Plan

Announces several changes to its executive team as well as cost restructuring.

04.27.22

cGMP Manufacture | Drug Development

Center for Breakthrough Medicines (CBM) Strengthens Capabilities to Meet Demand

CBM turned to Utah-based Navigator Business Solutions to implement a foundational ERP system that supports the process automation needed for continued expansion

Sponsored released by Navigator Business Solutions 04.26.22

Breaking News | Drug Development | Drug Discovery